Torrent Pharma Seeks CCI Approval for Rs 195 Billion JB Chemicals Deal

21 Jul 2025 CW Team

Ahmedabad-based Torrent Pharmaceuticals has sought clearance from the Competition Commission of India (CCI) to acquire a majority stake in J B Chemicals and Pharmaceuticals in a Rs 195 billion deal.

Upon completion, Torrent Pharmaceuticals will become India’s second most valuable pharmaceutical company.

The move follows Torrent’s June announcement to acquire a majority stake in J B Chemicals for Rs 195 billion.

“The proposed combination pertains to the acquisition of shareholding by Torrent Pharmaceuticals Ltd in J B Chemicals & Pharmaceuticals Ltd, followed by the merger of the target with the acquirer,” stated a notice filed with the CCI.

Torrent Pharmaceuticals, the flagship company of the Torrent Group, manufactures and sells pharmaceutical formulations across multiple therapeutic segments.

J B Chemicals & Pharmaceuticals is involved in manufacturing and marketing a wide range of formulations and active pharmaceutical ingredients (APIs), and also provides contract development and manufacturing organisation (CDMO) services.

The companies acknowledged horizontal overlaps in certain markets related to the manufacture and sale of pharmaceutical formulations in India.

In June, Torrent agreed to acquire 46.39 per cent stake from promoters Tau Investment Holdings Pte Ltd, an affiliate of global investment firm KKR, for around Rs 119.17 billion. Additionally, it will buy a further 2.80 per cent stake from certain JB Chemicals employees at Rs 1,600 per share, amounting to Rs 7.19 billion.

Following these purchases, Torrent will launch an open offer to acquire 26 per cent from the open market at Rs 1,639.18 per share, totalling Rs 68.43 billion, as per stock exchange norms.

This will be the second largest deal in the Indian pharmaceutical sector, after Sun Pharmaceutical Industries’ 2015 acquisition of Ranbaxy Laboratories. After the share purchase, JB Chemicals will merge into Torrent.

KKR had initially acquired a 65 per cent stake in JB Chemicals in 2020. Earlier this year, in March, KKR divested 5.8 per cent of its stake in JB Chemicals for Rs 14.6 billion via open market transactions.

Founded in 1976, JB Chemicals produces pharmaceuticals in areas including gastroenterology, dermatology and diabetes.

Torrent Pharmaceuticals, with annual revenues exceeding Rs 115 billion, is the flagship company of the Torrent Group, which generates group revenues of Rs 450 billion.

In a comparable major transaction, Sun Pharma announced in April 2014 its plan to acquire rival Ranbaxy for USD 4 billion in an all-stock deal, including USD 800 million in debt. The merger was completed after receiving regulatory approvals in March 2015.

Another significant recent deal saw Mankind Pharma acquire Bharat Serums and Vaccines last year for Rs 138 billion.

Ahmedabad-based Torrent Pharmaceuticals has sought clearance from the Competition Commission of India (CCI) to acquire a majority stake in J B Chemicals and Pharmaceuticals in a Rs 195 billion deal.Upon completion, Torrent Pharmaceuticals will become India’s second most valuable pharmaceutical company.The move follows Torrent’s June announcement to acquire a majority stake in J B Chemicals for Rs 195 billion.“The proposed combination pertains to the acquisition of shareholding by Torrent Pharmaceuticals Ltd in J B Chemicals & Pharmaceuticals Ltd, followed by the merger of the target with the acquirer,” stated a notice filed with the CCI.Torrent Pharmaceuticals, the flagship company of the Torrent Group, manufactures and sells pharmaceutical formulations across multiple therapeutic segments.J B Chemicals & Pharmaceuticals is involved in manufacturing and marketing a wide range of formulations and active pharmaceutical ingredients (APIs), and also provides contract development and manufacturing organisation (CDMO) services.The companies acknowledged horizontal overlaps in certain markets related to the manufacture and sale of pharmaceutical formulations in India.In June, Torrent agreed to acquire 46.39 per cent stake from promoters Tau Investment Holdings Pte Ltd, an affiliate of global investment firm KKR, for around Rs 119.17 billion. Additionally, it will buy a further 2.80 per cent stake from certain JB Chemicals employees at Rs 1,600 per share, amounting to Rs 7.19 billion.Following these purchases, Torrent will launch an open offer to acquire 26 per cent from the open market at Rs 1,639.18 per share, totalling Rs 68.43 billion, as per stock exchange norms.This will be the second largest deal in the Indian pharmaceutical sector, after Sun Pharmaceutical Industries’ 2015 acquisition of Ranbaxy Laboratories. After the share purchase, JB Chemicals will merge into Torrent.KKR had initially acquired a 65 per cent stake in JB Chemicals in 2020. Earlier this year, in March, KKR divested 5.8 per cent of its stake in JB Chemicals for Rs 14.6 billion via open market transactions.Founded in 1976, JB Chemicals produces pharmaceuticals in areas including gastroenterology, dermatology and diabetes.Torrent Pharmaceuticals, with annual revenues exceeding Rs 115 billion, is the flagship company of the Torrent Group, which generates group revenues of Rs 450 billion.In a comparable major transaction, Sun Pharma announced in April 2014 its plan to acquire rival Ranbaxy for USD 4 billion in an all-stock deal, including USD 800 million in debt. The merger was completed after receiving regulatory approvals in March 2015.Another significant recent deal saw Mankind Pharma acquire Bharat Serums and Vaccines last year for Rs 138 billion.

Infrastructure Urban

13 Mar 2026

Implementation Status of Jal Jeevan Mission

Since August 2019 the Government has implemented Jal Jeevan Mission to provide assured potable water through household tap connections in rural India. At the start of the mission only 32.3 million (mn) rural households, representing 16.7 per cent, were reported to have tap water connections. States and union territories have reported that 125.8 mn additional rural households have since been provided with tap connections. As a result, of about 193.6 mn rural households roughly 158.2 mn, or 81.71 per cent, are reported to have tap water supply at home.\n\nThe State, district and village level st..

Infrastructure Urban

13 Mar 2026

Jal Jeevan Mission Reaches Eighty One Per Cent Rural Coverage

The Government reported substantial progress under the Jal Jeevan Mission, launched in August 2019 to provide tap water to every rural household. At launch only 32.3 million (mn) rural households had tap connections and states and Union territories reported provision of 125.8 mn additional households by March 2026. Consequently, out of about 193.6 mn rural households around 158.2 mn, or 81.71 per cent, are reported to have tap water at home. The Finance Minister announced extension of the mission until 2028 in the 2025-26 budget speech. The Swachh Bharat Mission Grameen, launched in October 20..

Infrastructure Urban

13 Mar 2026

Empowering Local Governance for Sustainable Rural Water Supply

The Ministry of Jal Shakti has aligned the Jal Jeevan Mission (JJM) with the 73rd Amendment to strengthen village level planning and community ownership of water supply. Gram Panchayats, village water and sanitation committees and Pani Samitis are to plan, implement, manage and maintain piped water systems, with gram sabha processes formalising handover and oversight. Implementation support agencies including non government organisations, community based organisations and self help groups have been empanelled to train local committees and promote women participation. Under JJM, the department ..